# COMAR Title 14 — Independent Agencies

## Subtitle 17 — Maryland Cannabis Administration

### Chapter 04 — Medical Cannabis Program

#### Regulation .07 Clinical Directors.

*COMAR 14.17.04.07*

A. A licensed dispensary shall appoint at least one individual to function as clinical director who:

  (1) Is eligible to serve as a certifying provider, as defined in COMAR 14.17.01;

  (2) Is a licensed pharmacist in good standing with the State Board of Pharmacy; or

  (3) Has substantial education, training, and experience in the medical use of cannabis, as determined by the Administration and is a:

    (a) Registered nurse in good standing with the State Board of Nursing; or

    (b) Licensed naturopathic doctor in good standing with the State Board of Physicians.

B. During the hours of operation, a licensed dispensary shall have a clinical director:

  (1) On-site; or

  (2) Available via electronic communication.

C. A clinical director shall:

  (1) Register as a clinical director with the Administration;

  (2) Complete at least one training course each year that is approved by the Administration, which includes:

    (a) The latest scientific research on medical cannabis;

    (b) The risks and benefits of medical cannabis; and

    (c) Other information considered necessary by the Administration;

  (3) Educate qualifying patients and caregivers on:

    (a) Treatment of the qualifying patient’s medical condition with medical cannabis;

    (b) Potential drug-to-drug interactions, including interactions with alcohol, prescription drugs, non-prescription drugs, and supplements;

    (c) Possible side effects or contraindications of medical cannabis use;

    (d) The potential for differing strengths and effects of medical cannabis strains; and

    (e) Different methods, forms, and routes of medical cannabis administration; and

  (4) Provide training to dispensary agents on:

    (a) Guidelines for providing information to qualifying patients related to risks, benefits, and side effects associated with medical cannabis;

    (b) Recognizing signs and symptoms of substance abuse; and

    (c) Guidelines for refusing to provide medical cannabis to an individual who appears to be under the influence of drugs or alcohol.

D. A clinical director for a licensed dispensary may not provide a written certification for medical cannabis to any qualifying patient.

E. A standard dispensary is not subject to §§A—C of this regulation until the licensee has been licensed and operational for a period of at least 24 months.

F. A micro dispensary is not subject to §§A—C of this regulation.

G. The Administration may request information from licensed dispensaries on clinical director utilization in a manner specified by the Administration.